Vaso-occlusive Retinopathy Associated with Anti-phospholipid Antibodies (lupus anticoagulant retinopathy)

Ophthalmology

Volumn 96, Issue 6, 1989, Pages 896-904

  Kleiner, Robert C ^a   Najarian, Lawrence V ^b   Schatten, Sam ^b   Jabs, Douglas A ^c   Patz, Arnall ^c   Kaplan, Henry J ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

CASE REPORT; HUMAN; MALE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA BLOOD VESSEL OCCLUSION;

EID: 0024320657     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(89)32825-9     Document Type: Article

References (68)

1. Circulating anticoagulant as a cause of hemorrhagic diathesis in man
2. Observations on the characteristics of an unusual circulating anticoagulant
3. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus
4. Circulating anticoagulants: a study of 40 cases and a review of the literature
5. Acquired inhibitors of blood coagulation
6. Sequence of coagulation reactions
7. Principles of coagulation tests
8. Lupus anticoagulants
9. Monoclonal immunoglobulin M A coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant
10. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants
11. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant
12. Thromboembolism in patients with the ‘lupus’-type circulating anticoagulant
13. Thrombosis in systemic lupus erythematosus: relation to the presence of circulating anticoagulants
14. Lupus anticoagulants and thrombosis: a study of 25 cases and review of the literature
15. Possible relationship between lupus inhibitor and recurrent abortion in young women [Letter]
16. Lupus anticoagulant and pregnancy
17. Acquired inhibitors in nonhemophilic patients
18. Lupus anticoagulant and thrombosis in systemic lupus erythematosus [Letter]
19. Occlusive retinal vascular disease in systemic lupus erythematosus
20. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases
21. Thrombosis and immune disorders
22. Sudden painless vision loss and retinal artery occlusion
23. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases
24. Antiphospholipid antibodies associated with retinal vascular disease
25. Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies
26. Recurrent ischemic attacks in two young adults with lupus anticoagulant
27. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis
28. Visual symptoms associated with the presence of a lupus anticoagulant
29. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns
30. A clinical study of the lupus anticoagulant
31. The lupus anticoagulant
32. Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia
33. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure
34. Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations
35. Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant
36. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
37. The frequency of lupus anticoagulant in systemic lupus erythematosus: a study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level
38. Anti-phospholipid antibodies
39. Antiphospholipid antibodies: an elderly statesman dons new garments
40. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
41. Anticardiolipin antibodies and lupus anticoagulant [Letter]
42. The anticardiolipin syndrome
43. Thrombosis, recurrent fetal loss, and thrombocytopenia: Predictive value of the anticardiolipin antibody test
44. The lupus anticoagulant in 14 male patients
45. Thrombosis in patients with the lupus anticoagulant
46. The relationship between lupus anticoagulants and antibodies to phospholipid
47. Myocardial infarction in systemic lupus erythematosus and “lupus-like” disease [Letter]
48. The 1982 revised criteria for the classification of systemic lupus erythematosus
49. Retinopathy in systemic lupus erythematosus: a case report and review of the literature
50. Microangiopathy of the retinal arterioles
51. Central retinal artery occlusion
52. Retinopathy in systemic lupus erythematosus
53. Retinal arterial occlusive disease in systemic lupus erythematosus
54. Central retinal vein occlusion complicating systemic lupus erythematosus
55. Visual loss as the initial symptom of systemic lupus erythematosus
56. SLE retinopathy: evaluation by fluorescein angiography
57. Central retinal artery occlusion in systemic lupus erythematosus
58. Unilateral systemic lupus erythematosus retinopathy [Letter]
59. Proliferative lupus retinopathy
60. Cerebral and retinal vascular changes in systemic lupus erythematosus
61. Myocardial infarction with central retinal artery occlusion in a patient with antinuclear antibodynegative systemic lupus erythematosus
62. Severe retinal vaso-occlusive disease in systemic lupus erythematosus
63. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation
64. “Lupus” anticoagulant and thrombosispossible role of inhibition of prostacyclin formation
65. Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage
66. Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis
67. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal